These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17449093)
1. Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes. Lu Y; Kawakami S; Yamashita F; Hashida M Biomaterials; 2007 Jul; 28(21):3255-62. PubMed ID: 17449093 [TBL] [Abstract][Full Text] [Related]
2. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367 [TBL] [Abstract][Full Text] [Related]
4. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Kawakami S; Sato A; Nishikawa M; Yamashita F; Hashida M Gene Ther; 2000 Feb; 7(4):292-9. PubMed ID: 10694809 [TBL] [Abstract][Full Text] [Related]
5. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M Mol Pharm; 2011 Apr; 8(2):543-54. PubMed ID: 21250746 [TBL] [Abstract][Full Text] [Related]
6. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. Hattori Y; Kawakami S; Nakamura K; Yamashita F; Hashida M J Pharmacol Exp Ther; 2006 Aug; 318(2):828-34. PubMed ID: 16670348 [TBL] [Abstract][Full Text] [Related]
8. Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization. Srinivas R; Karmali PP; Pramanik D; Garu A; Mahidhar YV; Majeti BK; Ramakrishna S; Srinivas G; Chaudhuri A J Med Chem; 2010 Feb; 53(3):1387-91. PubMed ID: 20050668 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of the anti-tumor effect of DNA vaccination using an ultrasound-responsive mannose-modified gene carrier in combination with doxorubicin-encapsulated PEGylated liposomes. Yoshida M; Kawakami S; Kono Y; Un K; Higuchi Y; Maruyama K; Yamashita F; Hashida M Int J Pharm; 2014 Nov; 475(1-2):401-7. PubMed ID: 25218184 [TBL] [Abstract][Full Text] [Related]
11. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma. Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175 [TBL] [Abstract][Full Text] [Related]
12. Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice. Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M J Gene Med; 2008 Apr; 10(4):392-9. PubMed ID: 18181219 [TBL] [Abstract][Full Text] [Related]
13. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M Biomaterials; 2010 Oct; 31(30):7813-26. PubMed ID: 20656348 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant. Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911 [TBL] [Abstract][Full Text] [Related]
15. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming. Ulmer JB; Otten GR Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. Jérôme V; Graser A; Müller R; Kontermann RE; Konur A J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372 [TBL] [Abstract][Full Text] [Related]
17. Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice. Kawakami S; Hattori Y; Lu Y; Higuchi Y; Yamashita F; Hashida M Pharmazie; 2004 May; 59(5):405-8. PubMed ID: 15212310 [TBL] [Abstract][Full Text] [Related]
18. Melanoma vaccine based on the vector of membrane fusogenic liposomes. Qiang L; Yi J; Fu-De C Pharmazie; 2004 Apr; 59(4):263-7. PubMed ID: 15125569 [TBL] [Abstract][Full Text] [Related]
19. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity]. Tan XH; Wan YH Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382 [TBL] [Abstract][Full Text] [Related]
20. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model. Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]